Systemic bevacizumab for treatment of recurrent respiratory papillomatosis
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2024/01/05
-
Indian UGC (journal)
-
Refrences27
-
Citations2
-
Xiaoyun Zhao
-
Jiajia Wang
-
Qi Chen
-
Xiufa Wu
-
Wenjing Mao
-
Jingru Ma
-
Rui Fang
-
Peijie He
-
Chunsheng Wei ORCID (unauthenticated)
Journal Categories
Medicine
Medicine (General)
Medicine
Otorhinolaryngology
You May Also Like
- Psychometric validity of the 22‐item Sinonasal Outcome Test
- A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy
- Prognostic factors of neck node metastasis
- COVID-19 and anosmia: A review based on up-to-date knowledge
- Characterizations of life-threatening deep cervical space infections: A review of one hundred ninety-six cases
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why? | The Laryngoscope |
| 5 | 2023 |
Long‐Term Follow‐up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis | The Laryngoscope |
| 5 | 2023 |
| Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment | Anticancer Research |
| 4 | 2023 |
Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review | European Archives of Oto-Rhino-Laryngology |
| 14 | 2022 |
Systemic Bevacizumab Treatment for Recurrent Respiratory Papillomatosis: Long‐Term Follow‐Up | The Laryngoscope |
| 11 | 2022 |
Refrences Analysis
The category
Medicine: Otorhinolaryngology 24
is the most frequently represented among the references in this article. It primarily includes studies from The Laryngoscope and International Journal of Pediatric Otorhinolaryngology. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience | The Laryngoscope |
| 2024 | |
| Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis | Journal of Voice |
| 2024 |
Citations Analysis
| Category | Category Repetition |
|---|---|
| Medicine: Otorhinolaryngology | 2 |
| Medicine: Medicine (General) | 2 |
| Language and Literature: Philology. Linguistics: Communication. Mass media: Oral communication. Speech | 1 |
The category
Medicine: Otorhinolaryngology 2
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis and was published in 2024. The most recent citation comes from a 2024 study titled Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis. This article reached its peak citation in 2024, with 2 citations. It has been cited in 2 different journals. Among related journals, the Journal of Voice cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.